Co-Diagnostics Rallies On coronavirus Testing Opportunity


Co-Diagnostics (NASDAQ: CODX) is powering high in the market after announcing an increase in demand for its tests targeting the havoc, causing the COVID-19 virus. The company has especially received a boost on the U.S Food and Drug Administration encourages the use of its diagnostics tests.  Similarly, CBD Unlimited is also making a name for itself with a robust portfolio of CBD products.

Labs in the U.S can now use Co-Diagnostics test kits to test for COVID-19 even before they get formal regulatory approval.   The result has been an increase in orders from laboratories across the United States as the need to bring the virus under control continues to grow.

Coronavirus Stock to Watch

In addition to strong demand for the coronavirus test kits and reagents in the U.S, Co-Diagnostics is also eliciting strong demand abroad. The company has already started shipping its products to countries on four continents.  In a bid to keep up with the strong demand, the company intends to ramp up manufacturing as well as shipping operations.

Investors continue to push the stock up the charts; having become clear Co-Diagnostics is well-positioned to rip big from the massive opportunity at the back of the coronavirus epidemic.  The stock is already up by more than 1000% and showing no signs of slowing down.

Coronavirus Stock to Watch

Even as Co-Diagnostics continues to send shockwaves in the market, CBD Unlimited Inc. (OTC: EDCX) is also enjoying an impressive ride on the cannabis sector.

The company is increasingly making a name for itself on the development of CBD products targeting pain, anxiety as well as inflammation.

CBD Unlimited Inc. (OTC: EDCX) continues to strengthen its prospects in the burgeoning industry with a product pipeline made up of oil capsules as well as tropical and pet products. Similarly, its flagship product is Phyto-Bites, which are CBD chew targeting animals. The company differentiates itself from the competition on developing products with accurate dosage levels.

Likewise, CBD Unlimited Inc. (OTC: EDCX) is looking to make its products available in over 20,000 stores across the U.S from the current 5,600 stores. CBD Unlimited Inc. (OTC: EDCX) is also growing its international presence having secured permits to make its products available in South Africa and Puerto Rico.

Source: Stock Market Press

Join Stock Market Press’ newsletter for the latest in IPO, market commentary and company profiles.

Stock Market Press is a financial news company that delivers up to date stock news, introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network.


Stock Market Press
110 Wall St.
New York, NY 10005

Safe Harbor Statement:

Statements in this news release may be ”forward-looking statements.” Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release and Stock Market Press undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release.

See Stock Market Press disclaimer: SOURCE: Stock Market Press